3rd Quarter - Termination

FORBES-TATE for SYNDAX PHARMACEUTICALS

Firm
Client
Income
$20,000
Expenses
—
Terminated
Jul 15, 2020

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the advancement of research and development.

LobbyistCovered position, as disclosed
EDWARD C. RENO —
BARRETT THORNHILL —
WESLEY RYAN WELCH —
DERRICK M WHITE —
ZACHARY WILLIAMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Government Issues GOV

Issues related to the advancement of research and development.

LobbyistCovered position, as disclosed
EDWARD C. RENO —
BARRETT THORNHILL —
WESLEY RYAN WELCH —
DERRICK M WHITE —
ZACHARY WILLIAMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.